FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

412077000: Adrenal hormone agent (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2467529014 Adrenal hormone agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2473681016 Adrenal hormone agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Adrenal hormone agent Is a Adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Has disposition Adrenal hormone (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
    Adrenal hormone agent Is a Hormone false Inferred relationship Existential restriction modifier (core metadata concept)
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Adrenal cortex agent Is a False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing prednisone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing fluticasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluorometholone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Rimexolone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Loteprednol etabonate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing loteprednol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone tebutate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Triamcinolone hexacetonide (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Methylprednisolone sodium succinate (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Cortisone preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing alclometasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing clobetasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Clobetasone butyrate (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing deflazacort (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Diflucortolone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    diflucortolone valérate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluclorolone (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluclorolone acetonide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluocinonide topical preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing fluocortolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    produit contenant du caproate de fluocortolone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing glucocorticoid (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 3mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 3 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 25 milligram/1 each conventional release rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 100 mg/mL rectal foam The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Hydrocortisone acetate 25 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone (as prednisolone sodium phosphate) 5 mg rectal suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 20mg/100mL long tube retention enema The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Prednisolone 20mg/100mL standard tube retention enema The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide-containing product in rectal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 2mg/100mL enema The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Rectal compounds +corticosteroids The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely hydrocortisone 2 milligram/1 gram and lidocaine hydrochloride 10 milligram/1 gram conventional release cutaneous spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 400micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 400micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 50micrograms breath-actuated aerosol inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 250micrograms breath-actuated aerosol inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 100micrograms breath-actuated aerosol inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 250micrograms inhaler+compact spacer (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 250micrograms compact spacer refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 400micrograms inhalation capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 100micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 200micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 100micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 200micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 250micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 200micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 100micrograms inhalation capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 200micrograms inhalation capsule (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 100 microgram/actuation pressurised solution for inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate+salbutamol 200micrograms/400micrograms inhalation capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate+salbutamol 100micrograms/200micrograms pediatric inhalation capsule (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate+salbutamol 50micrograms/100micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 200micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 400micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 500micrograms/2mL nebulization unit (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 1mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 200micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 100micrograms/blister disks+disk inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 250micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50micrograms/blister disks refill (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 100micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 250micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 25micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 125micrograms inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 250micrograms inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 500micrograms/blister disks+disk inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 500micrograms/blister disks refill (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 250micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 500micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 0.5mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 2mg/2mL nebulization unit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Fluticasone propionate 50micrograms CFC-free inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclometasone dipropionate 100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Beclomethasone dipropionate 250micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Alclometasone dipropionate topical preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing amcinonide in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone valerate systemic preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Betamethasone benzoate topical preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)
    Budesonide systemic preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone agent Inferred relationship Existential restriction modifier (core metadata concept)

    Page 1 of 9 Next End

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start